Allergy Drug Allegra Cleared for Kids
Posted on: Wednesday, 18 October 2006, 18:01 CDT
Sanofi-aventis said Wednesday it has been approved for U.S. sales of allergy drug Allegra in children as young as 2 years of age.
The drug giant said the Food and Drug Administration has cleared its top-selling allergy medicine to treat symptoms associated with seasonal allergies in pediatric patients ages 2 to 11 years old and for the treatment of chronic idiopathic urticaria (CIU) in children 6 months to 11 years old.
Until now, parents had few seasonal antihistamine treatment options that were not associated with cognitively impairing adverse side effects, said Eli Meltzer of the Allergy and Asthma Medical Group and Research Center in San Diego.
However, with Allegra Oral Suspension, which does not cause sedation at any dose and is well-established for its antihistamine activity, a medication is now available in a good tasting, easy-to-swallow formulation that can help reduce the seasonal allergy symptoms of children, he said.
Symptoms of seasonal allergies include nasal drainage, sneezing, watery eyes and itchy nose, eyes and throat, while CIU is a rare disorder marked by hives lasting more than six weeks from an unknown cause beginning in the upper layers of the skin.
Source: United Press International
Related Articles
- Just in Time for Allergy Season, ZYRTEC(R) Provides New Solutions for Adults and Children
- BioRay's LiverLife Reduces Food Allergies in Autistic Children
- Rite Aid Pharmacists Can Help Patients Breathe Easier, Manage Symptoms and Find Relief This Allergy Season
- Study Says Allergy Shots Help Children, Reduce Health Care Costs
- Soaring Pollen Counts Spur Worst Allergy Season in Years
- VIDEO From Medialink: Learn How to Deal With Allergy Season While Playing on the Field
- Spring Has Arrived and With It, Allergy Season
- Spring is in Your Face ; Bloomin' Allergy Season Gets an Early Start This Year
- Allergy Season Can Mean Asthma Trouble for Some
- Warm Weather Spell Brings Early Allergy Season
User Comments (0)

RSS Feeds